Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 57757-57-0 | MDL No. : | MFCD00042045 |
Formula : | C14H16N2O8S2 | Boiling Point : | - |
Linear Structure Formula : | (SC2H4C(O)ON(C(O)CH2)2)2 | InChI Key : | FXYPGCIGRDZWNR-UHFFFAOYSA-N |
M.W : | 404.42 | Pubchem ID : | 93313 |
Synonyms : |
3,3′-Dithiodipropionic Acid di(N-hydroxysuccinimide ester);NSC 328386;DTSSP Crosslinker;Lomant's Reagent;DSP
|
Chemical Name : | Di(N-succinimidyl) 3,3-Dithiodipropionate [Cross-linking Reagent] |
Num. heavy atoms : | 26 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.57 |
Num. rotatable bonds : | 11 |
Num. H-bond acceptors : | 8.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 97.36 |
TPSA : | 177.96 Ų |
GI absorption : | Low |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -9.63 cm/s |
Log Po/w (iLOGP) : | 1.96 |
Log Po/w (XLOGP3) : | -1.21 |
Log Po/w (WLOGP) : | -0.4 |
Log Po/w (MLOGP) : | 0.38 |
Log Po/w (SILICOS-IT) : | 0.46 |
Consensus Log Po/w : | 0.24 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 2.0 |
Egan : | 1.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.86 |
Solubility : | 55.9 mg/ml ; 0.138 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.03 |
Solubility : | 3.75 mg/ml ; 0.00927 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.46 |
Solubility : | 13.9 mg/ml ; 0.0344 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 3.26 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 2 h; | To the solution of 3,3'-dithioldipropionic acid (1 g, 4.75 mmol) in dichloromethane (20 mL), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (WSC) (2.16 g, 10.5 mmol) and N-hydroxysuccinimide (1.21 g, 10.5 mmol) were added. The mixture was stirred for 2 h at room temperature. The solution was concentrated in vacuo, and the obtained residue was subjected to silica column chromatography (ethyl acetate/hexane = 1:5) to give the NHS ester 2 (1.63 g, 85percent). 1H NMR (DMSO-d6, 400 MHz) δ 3.16 (m, 8H), 2.82 (s, 8H). FAB (DMSO-d6) [(M+H)+] calcd 405, found 405. |
70% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; | One kind of bis(succinimidyl) 3,3'-dithiodipropionate synthesis, the following steps: -; Weigh 3,3'-thiodipropionic acid (6.0g, 0.028mol), N-hydroxysuccinimide (8.0g, 0.06mol), EDC hydrochloride (13g, 0.06 mol), into a 100mL round bottom flask, 40mL of methylene chloride was added, stirred at room temperature, the solid gradually dissolved overnight reaction, there is generated a white solid. Filtered and dried to give the product (8.05g, white solid), yield 70percent. |
49% | With dicyclohexyl-carbodiimide In dichloromethane; acetone at 20℃; for 24 h; | . 3,3'-Dithiobis(propanoic acid) (9.5 g, 45.2 mmol) was dissolved in a mixture of acetone (600 mL) and dichloromethane (600 mL) with stirring at room temperature. N-Hydroxysuccinimide (12.68 g, 110.2 mmol, 2.44 eq) was dissolved in the solution, then 1,3-dicyclohexylcarbodiimide (25.9 g, 125.5 mmol, 2.78 eq) was cautiously added. The mixture was allowed to stir at room temperature for 24 hours, after which time the solution was vacuum filtered and the residual solid discarded. The solvent was removed from the filtrate under vacuum, and the oily residue was redissolved in dichloromethane (ca 200 mL). The solution was reduced in volume (ca. 50 mL) and cooled, giving the product as a colourless, crystalline solid (8.90 g, 49percent yield). 1H-NMR (d6-DMSO): δ 2.80 (s, 8H), 3.05 (m, 8H). 13C-NMR (d6-DMSO): δ 25.8, 30.7, 32.3, 167.9, 170.4 ppm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 20℃; for 2h; | General procedure: Organic synthesisGeneral procedure for the synthesis of linker molecules (compound 1 and 2)To a solution of the di-acid (suberic acid or 3,3?-dithiodipropionic acid) (500 mg, 2.4 mmol) indry DCM (10 mL)was added EDC?HCI (1.37 g, 7.1 mmol) and N-hydroxysuccinimide (656.8mg, 5.7 mmol). The mixture was stirred for 2 hours at rt. The organic phase was washed witha 2.5% aqueous solution of NaHSO4 (2 x 10 mL) and brine (10 mL), dried over anhydrous Na2504, filtered and concentrated in vacuo. No further purification was performed. Both compounds 1 and 2 were isolated as white solids with full conversion. | |
...preferably 15 amino acids.When sc(Fv)2 contains three peptide linkers, their length may be all the same or different.For example, such peptide linkers include:Synthetic linkers (chemical crosslinking agents) is routinely used to crosslink peptides, and for example:N-hydroxy succinimide (NHS),disuccinimidyl suberate (DSS),bis(sulfosuccinimidyl) suberate (BS3),dithiobis(succinimidyl propionate) (DSP),dithiobis(sulfosuccinimidyl propionate) (DTSSP),ethylene glycol bis(succinimidyl succinate) (EGS),ethylene glycol bis(sulfosuccinimidyl succinate) (sulfo-EGS),disuccinimidyl tartrate (DST), disulfosuccinimidyl tartrate (sulfo-DST), |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 20℃; for 2h; | To the solution of 3,3'-dithioldipropionic acid (1 g, 4.75 mmol) in dichloromethane (20 mL), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (WSC) (2.16 g, 10.5 mmol) and N-hydroxysuccinimide (1.21 g, 10.5 mmol) were added. The mixture was stirred for 2 h at room temperature. The solution was concentrated in vacuo, and the obtained residue was subjected to silica column chromatography (ethyl acetate/hexane = 1:5) to give the NHS ester 2 (1.63 g, 85%). 1H NMR (DMSO-d6, 400 MHz) delta 3.16 (m, 8H), 2.82 (s, 8H). FAB (DMSO-d6) [(M+H)+] calcd 405, found 405. |
70% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 20℃; | One kind of bis(succinimidyl) 3,3'-dithiodipropionate synthesis, the following steps: -; Weigh 3,3'-thiodipropionic acid (6.0g, 0.028mol), N-hydroxysuccinimide (8.0g, 0.06mol), EDC hydrochloride (13g, 0.06 mol), into a 100mL round bottom flask, 40mL of methylene chloride was added, stirred at room temperature, the solid gradually dissolved overnight reaction, there is generated a white solid. Filtered and dried to give the product (8.05g, white solid), yield 70%. |
49% | With dicyclohexyl-carbodiimide; In dichloromethane; acetone; at 20℃; for 24h; | . 3,3'-Dithiobis(propanoic acid) (9.5 g, 45.2 mmol) was dissolved in a mixture of acetone (600 mL) and dichloromethane (600 mL) with stirring at room temperature. N-Hydroxysuccinimide (12.68 g, 110.2 mmol, 2.44 eq) was dissolved in the solution, then 1,3-dicyclohexylcarbodiimide (25.9 g, 125.5 mmol, 2.78 eq) was cautiously added. The mixture was allowed to stir at room temperature for 24 hours, after which time the solution was vacuum filtered and the residual solid discarded. The solvent was removed from the filtrate under vacuum, and the oily residue was redissolved in dichloromethane (ca 200 mL). The solution was reduced in volume (ca. 50 mL) and cooled, giving the product as a colourless, crystalline solid (8.90 g, 49% yield). 1H-NMR (d6-DMSO): delta 2.80 (s, 8H), 3.05 (m, 8H). 13C-NMR (d6-DMSO): delta 25.8, 30.7, 32.3, 167.9, 170.4 ppm. |
With dicyclohexyl-carbodiimide; In N,N-dimethyl-formamide; for 24h;Cooling with ice; | Under ice-cooling, 4.2504 g (0.02 mol) of <strong>[1119-62-6]3,3'-dithiodipropionic acid</strong> (DTPA)And 4.6036 (0.04 mol) of N-hydroxysuccinimide (HOSu) were dissolved in 20 mL of dimethylformamide;4.1266 g (0.02 mmol) of dicyclohexylcarbodiimide was dissolved in 20 mL of dimethylformamide;Under stirring, it was added dropwise to the reaction mixture, the reaction was stirred in an ice bath for 24 hours, filtered;It is then diluted with ethyl acetate and diluted hydrochloric acid is added to remove the remaining dicyclic urea.The solvent is then removed by evaporation to give a solid product which is washed three to five times with dilute hydrochloric acid and then ethyl acetate. The aqueous hydrochloric acid solution is removed and the solvent is removed by rotary evaporation to give the product, DTSP. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
53% | . L-Aspartic acid (0.42 g, 3.16 mmol) was mixed with sodium hydrogen carbonate (0.50 g, 5.95 mmol, 1.9 eq), then water (1 mL) was added. The sodium hydrogen carbonate was added to quench the acidic hydrogens present in L-aspartic acid. When evolution of carbon dioxide had subsided, the mixture was diluted with 0.5 M bicarbonate buffer, pH 9 (19 mL, 9.5 mmol). All solids dissolved with swirling and the solution was found to be pH 9. 3,3'-Dithiobis(propanoic acid, succinimidyl ester) (0.247 M in DMSO, 5 mL, 1.24 mmol) was added dropwise to the aqueous carbonate solution with strirring. Immediately, a white precipitate appeared, but upon vigorous shaking it redissolved. After 24 hours, during which time the mixture was periodically shaken, dichloromethane (1 mL) was added, and the mixture was again allowed to stand for 24 hours with periodic shaking. The solution, (pH 9) was acidified to pH 7 by the dropwise addition of 32% hydrochloric acid. The product was precipitated by the slow, dropwise addition of the solution to a stirred beaker of absolute ethanol (300 mL) at room temperature, giving a fluffy white precipitate which was collected by filtration and dried under vacuum, giving the product as a white solid (0.37 g, 53% yield). 13C-NMR (D2O): delta 33.2, 34.8, 37.2, 50.9, 175.6, 176.0, 176.4 ppm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
0.40 g (40%) | With m-chloroperoxybenzoic acid; In dichloromethane; chloroform; ethyl acetate; acetone; | In step 2 Dithio-bis-(succinimidyl propionate)-S,S-dioxide (DTSPO) was prepared by adding 0.91 g 85% m-chloroperoxybenzoic acid (in 50 ml chloroform) dropwise over an hour into a solution of 0.97 g dithio-bis-(succinimidyl propionate) (DTSP) in 350 ml chloroform. The reaction was stirred for 4 hrs. on ice, then 1 hr. at room temperature. The solvent was removed by rotary evaporation, and the residue washed with benzene. The crude product was extracted with 60 ml dioxane and precipitated with a minimum amount of hexane. Yield: 0.40 g (40%). The product migrated as a single spot on thin layer chromatography in two solvent systems. Rf in methylene chloride:acetone:formic acid 100:25:1=0.30; Rf in ethylacetate=0.50. IR peaks characteristic of the succinimide ester appeared at 1810, 1780 and 1680 cm-1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In dichloromethane; water; dimethyl sulfoxide; N,N-dimethyl-formamide; at 20℃; for 3h;Product distribution / selectivity; | To a solution of about 0.25 gm (1 mmole) of primaquine in 12.5 mL of about 60% DMF and 12% DMSO in water, was added about 0.35 gm (0.9 mmoles) of DTSP in 6 mL of about 16% CH2Cl2 in DMF. The solution of PQ-DTSP was mixed and put in the dark at rt for about 3 hours before preparing biocleavable conjugates with the following combinative agents.; Preparation X-A Biocleavable <strong>[90-34-6]Primaquine</strong>-Gamma Globulin Conjugate In this example (N45B), primaquine is coupled to gamma globulin protein to provide a biocleavable primaquine protein carrier. Nucleic acid, CCA or other active agent can then be coupled to the gamma globulin. To a solution of about 0.25 gm (1 mmole) of primaquine in 12.5 mL of about 60% DMF and 12% DMSO in water, was added about 0.35 gm (0.9 mmoles) of DTSP in 6 mL of about 16% CH2Cl2 in DMF. The solution of PQ-DTSP was mixed and put in the dark at rt for about 3 hours before preparing a biocleavable conjugate with the gamma globulin.; To a solution of about 0.25 gm (1 mmole) of primaquine in 12.5 mL of about 60% DMF and 12% DMSO in water, was added about 0.35 gm (0.9 mmoles) of DTSP in 6 mL of about 16% CH2Cl2 in DMF. The solution of PQ-DTSP was mixed and put in the dark at rt for about 3 hours before preparing a biocleavable conjugate with the HSA.; In this example (N45), primaquine is coupled to a polylysine peptide to provide a primaquine-peptide carrier. To a solution of about 0.25 gm (1 mmole) of primaquine in 12.5 mL of about 60% DMF and 12% DMSO in water, was added about 0.35 gm (0.9 mmoles) of DTSP in 6 mL of about 16% CH2Cl2 in DMF. The solution of PQ-DTSP was mixed and put in the dark at rt for about 3 hours before preparing a biocleavable conjugate with the gamma globulin. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; In N,N-dimethyl-formamide; at 20℃; for 16h; | For the preparation of the macromolecular derivatives of the phallotoxins, namely phalloidin and phallacidin, 2.0 mmol of toluene-4-sulfonic chloride was dissolved in 400 ul chloroform and added to 0.127 mmol of phalloidin or phallacidin dissolved in 1 ml ice cold pyridine, drop by drop under stirring. After 30 min the reaction was stopped by the addition of 20 ml diethylether. The precipitate was washed with another 20 ml of diethylether and separated by chromatography on Sephadex LH20 with an overall yield of 68 %. For reaction with ammonia, 0.42 mmol monotosyl-phalloidin or monotosyl-phallacadin were reacted with 40 ml ice cold ammonia in methanol (2.5 N), and evaporated after 120 min. Yield of amino-phalloidin and amino-phallacidin was ca. 90%. For coupling to macromolecules the toxin derivatives bearing the functional amino group were reacted with the homobifunctional cross-linking reagent dithiobis-(succinimidylpropionate, DSP). For this, 248 mumoles DSP were dissolved in 1.0 ml dimethylformamide and added to 63 mumoles of dried aminophalloidin. Reaction was started with 2 mul of triethylamine and proceeded under magnetic stirring for 16h at RT. The reaction product was precipitated with 10 ml diethylether and centrifugated, the sediment dissolved in 5 ml methanol and developed on a Sephadex-LH20 column using methanol. Yield of DSP-phalloidin or DSP-phallacidin was about 80 %, purity was minimum 90 %. For reaction with the macromolecules, 7 mg DSP-phalloidin was dissolved in 0.5 ml dimethylformamide and added to the macromolecule dissolved in 0.5 ml PBS. After reaction for 16h at RT, high-molecular weight products were separated by gelfiltration chromatography on Sephadex G-25 using 0.1% NaCl as solvent. After lyophilisation, yield was determined by measuring the characteristic absorption of phalloidin and phallacidin at 300 nm (epsilon=10100). We calculated that with polylysine, for example, one out of 10 lysine residues was conjugated with aminophalloidin or aminophallacidin. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In N,N-dimethyl-formamide; at 25℃; for 0.5h; | For activation of Pluronic block copolymer, 330 mg of Pluronic amine was first dissolved in 2.5 mL of methanol and added dropwise to a stirring solution of 80 mg of dithiobis(succinimidyl) propionate (DSP) in 2.5 mL of DMF at 25 C. Following the 30 min reaction, the DSP modified Pluronic was isolated by gel filtration on Sephadex LH 20 column (2.5×30 cm) in methanol (fractions 8 mL/4 min). TLC: Rf 0.5-0.6 (Merck Silicagel plates, dichloromethane-methanol, 9:1). The product developed yellow color after exposure of TLC plates to iodine vapors (test on the presence of Pluronic polymers). Polymer-containing fractions were collected and concentrated in vacuo. The N-hydroxysuccinimidocarboxyl (NHS) product (Pluronic-NHS) was dissolved in 1.5 mL of 20% ethanol immediately before reaction with protein |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | With sodium hydroxide; In chloroform; water; for 0.5h;pH 10; | A 20 mL scintillation vial was charged with a solution of 92.6 mg (7.65 x 10-5 mol) of the bis(hydrogen carbonate) salt of 4 in 1 mL of water. The pH of the solution was adjusted to 10 with 1 M NaOH before a solution of 30.9 mg (7.65 x 10-5 mol) of dithiobis(succinimidyl propionate) (DSP, Pierce Chemical Co. of Rockford, IL) in 1 mL of chloroform was added. The resulting biphasic mixture was agitated with a Vortex mixer for 0.5 h. The aqueous layer was then decanted and extracted with 3 x 1 mL of fresh chloroform. The aqueous polymer solution was then subjected to gel permeation chromatography (GPC) on Toyopearl HW-40F resin using water as eluant. Fractions were analyzed by GPC and appropriate fractions were lyophilized to yield 85 mg (85%) as a colorless amorphous powder. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium hydroxide; In chloroform; water; for 0.5h;pH 10; | A 8 mL vial was charged with a solution of 102.3 mg (8.80 x 10-5 mol) of 2A,3A-diamino-2A,3A-dideoxy-beta-cyclodextrin in 1 mL of water. The pH of the solution was adjusted to 10 with 1 M NaOH before a solution of 36.4 mg (8.80 x 10-5 mol) of dithiobis(succinimidyl propionate) (DSP, Pierce Chemical Co. of Rockford, IL) in 1 mL of chloroform was added. The resulting biphasic mixture was agitated with a Vortex mixer for 0.5 h. The aqueous layer was then decanted and extracted with 3 x 1 mL of fresh chloroform. The aqueous polymer solution was then subjected to gel permeation chromatography. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In N,N-dimethyl-formamide; at 40℃; for 24h; | Tyramine (0.24g, 1.75mmol) was added to a solution of DIC (0.12g, 0.35mmol) in isopropanol (15mL). The reaction mixture was stirred for 24 h at 40C. The mixture was concentrated and purified by column chromatography (EtOAc) to give tyramine- DIC (0.1 Og, 99%) as light yellow solid. Tyramine (0.24g, 1.75mmol) was added to a solution of DSP (0.14g, 0.35mmol) in DMF (4mL). The reaction mixture was stirred for 24 h at 40C. The reaction was stopped by adding water (15 mL) to the reaction mixture. Then the product was filtered and washed with water (10 mL) three times. The product tyramine-DSP (light yellow solid) was then dried and weighed (0.1 lg). The products tyramine-DSP and tyramine -DIC were added to dithiothreitol solution (50 mM, PBS) at 37 C and stirred for 24 h . Then the solutions were lyophilized. Isopropanol (1 mL) was added to the powder acquired and bath sonicated for 15 min. The supernatants from the solutions were collected and analyzed by gas chromatography-mass spectrometry (Alilent Technologies 5975 series MSD, 7820A GC system) and untreated tyramine was used as standard.Tyramine generated from tyramine-DIC was purified through thin layer chromatography (TLC) (EtOAc 90%, methanol 10%). 1H NMR (bruker Avance 400WB) and mass spectrometry (Agilent technologies 6210 LC-TOF) were used to confirm the structure of the compound. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; In dimethyl sulfoxide; at 20℃; for 5h; | Ac-IR7 (0.3 mg, 355 mumol) was dissolved in DMSO (275 muL) and 14 muL of a 1mMDSP solution was added (1 eq.) along with diisopropylethylamine (0.2 muL, 1 eq.). The mixture was incubated at room temperature for 5 h with periodic mixing, before being concentrated to dryness using a SpeedVac concentrator. The residue was dissolved in water and desalted by ZipTip (Millipore, Bedford, MA, USA) before MS analysis. These non-physiological experimental conditions were employed to attain high yields of the cross-linked products for analysis, allowing for characterization of the fragmentation pathways with relative ease from this model system. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | With N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 2h; | 8 mg (10 mumol) of Intermediate 101 were dissolved in 2 ml of DMF and admixed with 8.6 mg (20 mumol) of 1,1?-{-disulphanediylbis[(1-oxopropane-3,1-diyl)oxy]dipyrrolidine-2,5-dione and 3.7 mul of N,N-diisopropylethylamine. The reaction mixture was stirred at RT for 2 h and then the solvent was evaporated off under reduced pressure and the residue was purified by preparative HPLC. 7.2 mg (68% of theory) of the title compound were obtained. [2313] HPLC (Method 5): Rt=1.9 min; [2314] LC-MS (Method 11): Rt=0.94 min; MS (ESIpos): m/z=615 [ (M+2H+] |
68% | With N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 2h; | [4692] 8 mg (10 f.tmol) oflntermediate 101 were dissolvedin 2 ml of DMF and admixed with 8.6 mg (20 f.tmol) of1, 1 '-{ disulphanediy Ibis [ ( 1-oxopropane-3, 1-diyl )oxy]dipyrrolidine-2,5-dione and 3.7 fll ofN,N-diisopropylethylamine.The reaction mixture was stirred at RT for 2 h, andthen the solvent was evaporated off in vacuo, and the residuewas purified by means of preparative HPLC. 7.2 mg (68% oftheory) of the title compound were obtained.[4693] HPLC (Method 5): R,=l.9 min;[4694] LC-MS (Method 11): R,=0.94 min; MS (ESipos):m/z=615 [I/2 (M+2W] |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
32% | With N-ethyl-N,N-diisopropylamine; In dimethyl sulfoxide; at 20℃; for 24h; | Detailed description of the synthesis and characterization of TPETP-NH2 can be found in the Supplementary Methods. Amine terminated DEVD-TPS-cRGD (10.0 mg, 6.0 mupiiotaomicron) and TPETP-NH2 (3.6 mg, 6.0 muetaiotaomicron) were dissolved in anhydrous DMSO (1.0 mL) in the presence of DIPEA (1.0 mu). The mixture was stirred for 10 min at room temperature. Then dithiobis(succinimidyl propionate) (DSP, 2.4 mg, 6.0 muiotaetaomicron) in DMSO (0.5 mL) was added quickly to the above solution. The reaction was continued with stirring at room temperature for another 24 h. The final product was obtained after purification using preparative HPLC and lyophilized under vacuum to yield the probe TPETP-SS-DEVD-TPS-cRGD as yellow powders in 32% yield (4.7 mg). HPLC (lambda = 320 nm): purity 97.3%, retention time 12.3 minutes; ESI-MS: m/z [M+2H]2+ calc. 1216.945, found 1215.916. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | The synthetic route for compound 94 is outlined in Figure 3. (0810) DTT method: Compound 29 (5 mg, 0.003 mmol) was dissolved in pH 7.4 PBS buffer (5 mL) and DSP (dithiobis(succinimidyl propionate)) (20 mg, 0.049 mmol) in DMSO (2.5 mL) was added at room temperature overnight. After that, dithiothreitol (DTT) (4 mg, 0.025 mmol) was added and the solution stirred at 40 C for further 2 h. Compound 91 was purified through Sephadex G-25 column chromatography (4.5 mg, 88%). HRMS (ESI+) Calcd for C5iH99NO46P S [M+2Na+2K-4H]" 1736.2793, found 1736.279. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
29% | In dimethyl sulfoxide; at 20℃; | General procedure: 94 mg (0.2 mmol) N4Py-propylamine (1) and 48 mg (0.1 mmol) 2-Aminoethylfolic acid gamma-amide (2) were dissolved in 10 mL DMSO with assistance of mild heating and sonication. A catalytic amount of triethylamine (0.04 mL) and 74 mg (0.2 mmol) DSS (3) were added successively and the mixture was stirred at r.t. overnight. The mixture was then filtered to remove any trace of solid residue and the filtrate was slowly added to vigorously stirred diethyl ether (100 mL). After standing for 1 minute, the ether was decantedcarefullyand the remaining sticky yellow solid was treated with another 100 mL diethyl ether and vigorous stirring. After decanting the ether, the sticky yellow solid was washed with 2x50 mL MeOH and 1x50 mL diethyl ether. After each washing step the suspension was homogenized using a sonication bath and the solid was collected by centrifugation (5 min, at 4000 rpm). 34 mg (0.03 mmol, 31%) of a bright yellow solid was obtained. For cell studies, an analytically pure sample was obtained by preparative RP-HPLC (linear gradient 90% B to 30% B in 40 minutes, flow: 1.0 mL/min, solvent A: acetonitrile B: ammonium formate 5 mM pH = 8.5). Analytical rp-HPLC (linear gradient 90% B to 30% B in 40 minutes, flow: 0.5 mL/min, solvent A: acetonitrile B: ammonium formate 5mM pH=8.5) TR= 24.7 min. LC-MS (ESI+) m/z: 1089.5 [M+H]+, 1111.5 [M+Na]+, 795.4 [M - Pteroic acid + 2H]+, 545.3 [M+2H]2+, 363.8 [M+3H]3+, 295.1 [Pteroic acid]+. HRMS (ESI+) calcd for C56H65N16O8+[M+H]+: 1089.517, found 1089.516. |
Tags: 57757-57-0 synthesis path| 57757-57-0 SDS| 57757-57-0 COA| 57757-57-0 purity| 57757-57-0 application| 57757-57-0 NMR| 57757-57-0 COA| 57757-57-0 structure
[ 30364-60-4 ]
Bis(2,5-dioxopyrrolidin-1-yl) succinate
Similarity: 0.83
[ 30364-55-7 ]
2,5-Dioxopyrrolidin-1-yl propionate
Similarity: 0.83
[ 69888-86-4 ]
2,5-Dioxopyrrolidin-1-yl tetradecanoate
Similarity: 0.82
[ 14464-30-3 ]
2,5-Dioxopyrrolidin-1-yl octanoate
Similarity: 0.82
[ 14464-31-4 ]
Palmitic acid N-hydroxysuccinimide ester
Similarity: 0.82
[ 30364-60-4 ]
Bis(2,5-dioxopyrrolidin-1-yl) succinate
Similarity: 0.83
[ 30364-55-7 ]
2,5-Dioxopyrrolidin-1-yl propionate
Similarity: 0.83
[ 69888-86-4 ]
2,5-Dioxopyrrolidin-1-yl tetradecanoate
Similarity: 0.82
[ 14464-30-3 ]
2,5-Dioxopyrrolidin-1-yl octanoate
Similarity: 0.82
[ 14464-31-4 ]
Palmitic acid N-hydroxysuccinimide ester
Similarity: 0.82
[ 30364-60-4 ]
Bis(2,5-dioxopyrrolidin-1-yl) succinate
Similarity: 0.83
[ 30364-55-7 ]
2,5-Dioxopyrrolidin-1-yl propionate
Similarity: 0.83
[ 69888-86-4 ]
2,5-Dioxopyrrolidin-1-yl tetradecanoate
Similarity: 0.82
[ 14464-30-3 ]
2,5-Dioxopyrrolidin-1-yl octanoate
Similarity: 0.82
[ 14464-31-4 ]
Palmitic acid N-hydroxysuccinimide ester
Similarity: 0.82
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :